Study on Patent Eligibility of Gene Invention in U.S. Patent Act
碩士 === 國立中興大學 === 法律學系碩士在職專班 === 102 === In 1980, the U.S. Supreme Court ruled that engineered organisms could be patented. For 30 years, genes have likewise been presumed to be eligible for patents. Recent Myriad case suggest that the Court may reverse established practice in biotechnology patents,...
Main Authors: | Tien-Hsiang Wang, 汪天祥 |
---|---|
Other Authors: | 林昱梅 |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/48080646237629247610 |
Similar Items
-
The Protection of Inventions for Cancer Gene Therapy: Focusing on Patent Eligibility
by: Chien-Liang Lin, et al.
Published: (2014) -
A Comparative Study of Patent Eligibility of Invention -Focused on Algorithm-
by: Cheng Chieh Huang, et al.
Published: (2019) -
Patent Eligibility of Computer Software Invention - Focused on Business Method
by: Hung, Cheng Sheng, et al. -
The Study on the U.S. Business Method Patent Eligibility- Featuring Alice Case
by: YANG,YUN, et al.
Published: (2016) -
The Distinction between Discovery and Invention in U.S. Patent Law
by: Chia-WeiHung, et al.
Published: (2018)